Rare Melanomas Prove 'Hard to Get' Using Immunotherapy

Dr Jeffrey Weber assesses the benefit of immunotherapies in two rare subtypes of melanoma and finds that rates of survival and duration of response trail well behind those associated with cutaneous melanoma.
Medscape Oncology

http://ift.tt/2mEGAU4